ABDX vs. YGEN, GENI, VRCI, AGL, PRM, GDR, DMTR, LLAI, LLA, and IDHC
Should you be buying Abingdon Health stock or one of its competitors? The main competitors of Abingdon Health include Yourgene Health (YGEN), GENinCode (GENI), Verici Dx (VRCI), ANGLE (AGL), Proteome Sciences (PRM), genedrive (GDR), Deepmatter Group (DMTR), LungLife AI (LLAI), LLA.L,0P0001T9GN,0 (LLA), and Integrated Diagnostics (IDHC). These companies are all part of the "diagnostics & research" industry.
Abingdon Health vs. Its Competitors
Abingdon Health (LON:ABDX) and Yourgene Health (LON:YGEN) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, analyst recommendations, profitability, dividends and earnings.
In the previous week, Abingdon Health had 1 more articles in the media than Yourgene Health. MarketBeat recorded 1 mentions for Abingdon Health and 0 mentions for Yourgene Health. Abingdon Health's average media sentiment score of 0.00 equaled Yourgene Health'saverage media sentiment score.
Abingdon Health has higher earnings, but lower revenue than Yourgene Health. Abingdon Health is trading at a lower price-to-earnings ratio than Yourgene Health, indicating that it is currently the more affordable of the two stocks.
Abingdon Health has a net margin of -20.72% compared to Yourgene Health's net margin of -27.55%. Yourgene Health's return on equity of -27.06% beat Abingdon Health's return on equity.
Abingdon Health has a beta of 0.13, meaning that its share price is 87% less volatile than the S&P 500. Comparatively, Yourgene Health has a beta of 0.86, meaning that its share price is 14% less volatile than the S&P 500.
1.9% of Abingdon Health shares are owned by institutional investors. Comparatively, 23.3% of Yourgene Health shares are owned by institutional investors. 10.4% of Abingdon Health shares are owned by company insiders. Comparatively, 64.4% of Yourgene Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Summary
Yourgene Health beats Abingdon Health on 7 of the 11 factors compared between the two stocks.
Get Abingdon Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for ABDX and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Abingdon Health Competitors List
Related Companies and Tools
This page (LON:ABDX) was last updated on 9/29/2025 by MarketBeat.com Staff
